HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jean C Grégoire Selected Research
Jean C Grégoire Research Topics
Disease
4
Acute Coronary Syndrome
11/2021 - 05/2010
4
Myocardial Infarction
11/2021 - 12/2019
3
Atherosclerotic Plaque (Atheroma)
11/2021 - 05/2010
3
Inflammation (Inflammations)
11/2021 - 08/2016
2
Atherosclerosis
11/2021 - 05/2010
2
Gout
01/2021 - 12/2019
2
Stroke (Strokes)
01/2021 - 11/2020
2
Pneumonia (Pneumonitis)
01/2021 - 12/2019
2
Pericarditis
01/2021 - 12/2019
2
Heart Arrest (Cardiac Arrest)
01/2021 - 11/2020
2
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
11/2020 - 01/2018
2
Hypertension (High Blood Pressure)
01/2017 - 01/2016
1
Coronary Artery Disease (Coronary Atherosclerosis)
11/2021
1
Rupture
11/2021
1
Peripheral Arterial Disease
11/2021
1
Coronary Disease (Coronary Heart Disease)
01/2021
1
COVID-19
01/2021
1
Prostatic Neoplasms (Prostate Cancer)
09/2020
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2020
1
Diarrhea
12/2019
1
Xanthomatosis (Xanthoma)
01/2018
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2018
1
Heart Failure
01/2018
1
Isolated Systolic Hypertension
01/2017
1
Frailty
01/2017
1
Stable Angina
01/2016
1
Hyperaldosteronism (Conn Syndrome)
01/2016
1
Hyperkalemia
01/2016
1
ST Elevation Myocardial Infarction
05/2013
1
Non-ST Elevated Myocardial Infarction
05/2013
1
Coronary Restenosis
03/2002
Drug/Important Bio-Agent (IBA)
5
Colchicine
FDA Link
Generic
11/2021 - 12/2019
2
Lipids
IBA
11/2020 - 01/2016
2
Leukotrienes
IBA
04/2017 - 05/2010
2
atreleuton
IBA
04/2017 - 05/2010
2
Arachidonate 5-Lipoxygenase (5 Lipoxygenase)
IBA
04/2017 - 05/2010
1
Interleukins
IBA
11/2021
1
Spironolactone (Aldactone)
FDA Link
Generic
11/2021
1
Interleukin-6 (Interleukin 6)
IBA
11/2021
1
Cytokines
IBA
11/2021
1
Anti-Inflammatory Agents (Anti-Inflammatories)
IBA
01/2021
1
Androgens
IBA
09/2020
1
Apolipoproteins B (ApoB)
IBA
01/2018
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
01/2018
1
Lipoproteins (Lipoprotein)
IBA
01/2018
1
LDL Cholesterol
IBA
01/2018
1
Angiotensin Receptors (Angiotensin II Receptor)
IBA
01/2018
1
Angiotensin Receptor Antagonists
IBA
01/2018
1
Neprilysin (Neutral Endopeptidase)
IBA
01/2018
1
oxidized low density lipoprotein
IBA
01/2018
1
DNA (Deoxyribonucleic Acid)
IBA
01/2018
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2017
1
dalcetrapib
IBA
08/2016
1
Cholesterol
IBA
08/2016
1
Dietary Potassium
IBA
01/2016
1
Calcium Channel Blockers (Blockers, Calcium Channel)
IBA
01/2016
1
P-Selectin
IBA
05/2013
1
inclacumab
IBA
05/2013
1
Lipoxygenase Inhibitors
IBA
05/2010
1
Antioxidants
IBA
03/2002
1
Probucol (Lorelco)
FDA Link
03/2002
Therapy/Procedure
5
Therapeutics
01/2021 - 01/2016
2
Percutaneous Coronary Intervention
11/2021 - 05/2013
1
Stents
11/2021
1
Secondary Prevention
11/2021
1
Time-to-Treatment
11/2020
1
Oral Administration
04/2017
1
Adrenalectomy
01/2016